Only 38% of pharma companies have started CMO on-boarding. Are you sure that your CMOs and 3PLs are ready for the EU-FMD deadline?
May 2, 2017
Is Europe ready for the EU-FMD? We talk to Pharmaceutical Manufacturing and Packing Sourcer (PMPS)
May 17, 2017

We partner NEXUS 17: Ensuring drug availability in EMEA with a Digital Supply Network

What: conference
When: 7-8 June
Where: Barcelona
Cost: use code EXCEL for a €100 discount

Nexus 17 will prepare you for the EU-FMD and the DSCSA. Attendees will bring home actionable learning as well as having a unique opportunity to collaborate with peers from across the supply chain. What you will learn:

  • Serialization readiness.
    Hear case studies from pharma executives on the critical issues facing all markets
  • EU-FMD challenges.
    Understand these challenges and how to work with the EU hub and national systems
  • DSCSA guidance.
    Get the last minute updates on U.S serialization and implementation considerations.
  • The latest developments
    in Russia, Saudi Arabia, Brazil and other regulations
  • Value beyond compliance.
    Realise the potential that compliance can achieve for your business

3C Excellis Europe’s core business is supporting pharma companies – brand owners, generic manufacturers and contract packagers, world-wide enterprises, small specialised companies – in planning, refining and delivering their serialization programs. We are the global leader in track and trace and cover all aspects of complex implementation programs from line-based equipment to ERP-level IT systems, all aspects of coding and master data, validation, partner on-boarding and supply chain integration. 3C Excellis Europe is a subsidiary of Excellis Health Solutions.


Show all

Comments are closed.